Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Blonanserin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119143672B reveals efficient blonanserin synthesis. Reduces steps from five to three. Offers supply chain reliability and cost reduction for pharmaceutical manufacturing partners.
Patent CN101747273B reveals a novel two-step synthesis for Blonanserin intermediates, boosting yield from 17% to 80% and ensuring reliable pharmaceutical intermediates supply.
Novel patent CN104447551A outlines high-yield blonanserin production. Offers cost reduction and supply chain reliability for global pharmaceutical manufacturers seeking scalable solutions.
Novel safe synthesis route for Blonanserin intermediate using potassium tert-butoxide. High purity scalable process for pharmaceutical supply chains.
Novel cascade cyclization patent reduces steps for blonanserin manufacturing offering cost and supply chain advantages for pharmaceutical partners globally.
Patent CN102887856A reveals a novel sulfonylation route for Blonanserin, offering superior purity and safety over traditional chlorination for API manufacturing.
Patent CN111233707B reveals a high-yield synthesis of 4-fluorobenzoylacetonitrile using triflic acid, offering significant cost reduction in pharmaceutical intermediates manufacturing.